Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.... Dec 11
... Dec 11
Bristol Myers Squibb today announced that its wholly-owned subsidiary, Celgene, and Cipla have settled their litigation related to patents for REVLIMID.... Dec 11
If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
-Advertisements-